Objective To discern presymptomatic changes in brain structure or function using advanced MRI in carriers of mutations predisposing to amyotrophic lateral sclerosis (ALS). Methods T1-weighted, diffusion weighted and resting state functional MRI data were acquired at 3 T for 12 asymptomatic mutation carriers (psALS), 12 age-matched controls and affected patients with ALS. Cortical thickness analysis, voxel-based morphometry, volumetric and shape analyses of subcortical structures, tract-based spatial statistics of metrics derived from the diffusion tensor, and resting state functional connectivity (FC) analyses were performed. Results Grey matter cortical thickness and shape analysis revealed significant atrophy in patients with ALS (but not...
OBJECTIVE: To understand the progressive nature of amyotrophic lateral sclerosis (ALS) by investigat...
Objective.Advanced neuroimaging techniques may offer the potential to monitor disease progression in...
The classical concept that amyotrophic lateral sclerosis (ALS) is a degenerative disorder characteri...
Objective: We sought to assess cortical function in amyotrophic lateral sclerosis (ALS) using noninv...
MRI has emerged as one of several urgently needed candidate disease progression biomarkers for the n...
Objective We sought to assess cortical function in amyotrophic lateral sclerosis (ALS) using noninva...
Objective: Advanced neuroimaging techniques may offer the potential to monitor disease spreading in ...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, characterized by progressi...
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterised by moto...
Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterised by moto...
r r Abstract: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, characterize...
Neurodegenerative process in amyotrophic lateral sclerosis (ALS) has been proven to involve several ...
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterised by motor neuron deg...
We investigated whether the functional connections to the primary sensorimotor cortex (SMC) at rest ...
OBJECTIVE: To understand the progressive nature of amyotrophic lateral sclerosis (ALS) by investigat...
Objective.Advanced neuroimaging techniques may offer the potential to monitor disease progression in...
The classical concept that amyotrophic lateral sclerosis (ALS) is a degenerative disorder characteri...
Objective: We sought to assess cortical function in amyotrophic lateral sclerosis (ALS) using noninv...
MRI has emerged as one of several urgently needed candidate disease progression biomarkers for the n...
Objective We sought to assess cortical function in amyotrophic lateral sclerosis (ALS) using noninva...
Objective: Advanced neuroimaging techniques may offer the potential to monitor disease spreading in ...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, characterized by progressi...
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterised by moto...
Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterised by moto...
r r Abstract: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, characterize...
Neurodegenerative process in amyotrophic lateral sclerosis (ALS) has been proven to involve several ...
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterised by motor neuron deg...
We investigated whether the functional connections to the primary sensorimotor cortex (SMC) at rest ...
OBJECTIVE: To understand the progressive nature of amyotrophic lateral sclerosis (ALS) by investigat...
Objective.Advanced neuroimaging techniques may offer the potential to monitor disease progression in...
The classical concept that amyotrophic lateral sclerosis (ALS) is a degenerative disorder characteri...